Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF) Short Interest Down 38.1% in October

Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 768,900 shares, a decline of 38.1% from the October 15th total of 1,242,600 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ? days.

Jacobio Pharmaceuticals Group Price Performance

Shares of OTCMKTS:JBPHF opened at $0.30 on Friday. Jacobio Pharmaceuticals Group has a 12 month low of $0.30 and a 12 month high of $0.30. The business’s 50 day simple moving average is $0.30 and its 200-day simple moving average is $0.30.

About Jacobio Pharmaceuticals Group

Jacobio Pharmaceuticals Group Co, Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein.